News
6d
MedPage Today on MSNFDA Scrutiny of Novavax COVID Shot Sparks Uncertainty About Other VaccinesThe unusual move at FDA comes shortly after the agency's longtime vaccine chief was forced out over disagreements with Makary ...
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
5dOpinion
MedPage Today on MSNInside the FDA: Low Morale and Uncertainty Plague StaffSeveral current and former FDA employees who spoke to Inside Medicine on the condition of anonymity have come to see the ...
The potential change outlined in a statement would require all new vaccines to undergo placebo testing, sparking concerns ...
If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...
Novavax announces significantly improved terms for collaboration and license pact with Takeda for Nuvaxovid in Japan: Gaithersburg, Maryland Tuesday, May 6, 2025, 14:00 Hrs [IST] ...
1d
Zacks Investment Research on MSNNovavax to Report First-Quarter Earnings: Is a Beat in Store?We expect Novavax NVAX to surpass expectations when it reports first-quarter 2025 earnings on May 8, before the opening bell.
Robert F. Kennedy Jr plans to change how vaccines are tested in the US, a decision that could impact how quickly and widely vaccines are made available.
Robert F. Kennedy Jr., who oversees the FDA, intends to set new regulatory standards vaccine manufacturers couldn’t possibly ...
The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine is sowing uncertainty about other ...
Our current Medical Establishment doesn't seem to grasp that they are no longer just Fox News and Twitter celebrities who can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results